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Abstract
Effects of the systemic administration of xymedon and its derivatives-L-ascorbate and para-
aminobenzoate 1,2-dihydro-4,6-dimethyl-l-(2-hydroxyethyl) pyrimid-2-one (compounds 29D and
34D, respectively) - have been studied on a contusion model (Th8 level) of spinal cord injury in
rats. Experiments showed the impact of treatment on recovery of motor function, spinal cord
tissue safety, population and phenotypic characteristics of astrocytes in the zones of gray and
white matter. Xymedon produced a stimulating effect on recovery of the locomotor function. In
this  respect,  compounds  29D  and  34D  were  more  effective  than  xymedon,  although  no
significant differences between the action of compounds 29D and 34D was observed. Each of
the three investigated pyrimidine derivatives significantly reduced the total area of pathologic
cavities in spinal cord. In this respect, compounds 29D and 34D were also more effective than
xymedon. Compound 29D exhibited a more pronounced effect in the dorsal root entry zone
(DREZ), while compound 34D more significantly supported preservation of tissue in the ventral
horns (VHs). Within 60 days after administration of compounds of 29D and 34D, the number of
GFAP+ astrocytes in gray matter zones decreased as compared to the group treated with
xymedon, and the expression of this marker protein of intermediate filaments decreased. In the
white matter, the number of GFAP+ cells increased under the influence of compound 29D and
decreased under the action of compound 34D. Differences between the effects of compounds
29D and 34D (on the background of their equal influence on recovery of the locomotor function)
may be indicative of different cellular and molecular mechanisms of action, in agreement with
data on their action on tissue safety.
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